Research Article - Biomedical Research (2017) Volume 28, Issue 15
Interleukin-6-572C/G polymorphism is associated with the risk of chronic periodontitis
Department of Stomatology, People's Hospital of Henan Province, Zhengzhou 450000, Henan, PR China
- *Corresponding Author:
- Dan Shi
Department of Stomatology
People's Hospital of Henan Province, PR China
Accepted date: June 15, 2017
Previous studies investigated the association between the IL-6-572C/G polymorphism and chronic periodontitis risk. However, the results were inconclusive. Therefore, we performed this study to assess the association between IL-6-572C/G polymorphism and chronic periodontitis risk. We included 231 patients with chronic periodontitis and 259 healthy controls. IL-6 sequence amplification was done using polymerase chain reaction (PCR). Subjects with CG genotype showed an increased risk of chronic periodontitis (OR=1.52, 95%CI 1.06-2.21). In addition, individuals with GG genotype had a higher risk of chronic periodontitis (OR=4.53, 95%CI 1.43-14.21). Carriage of the G-allele was significantly associated with chronic periodontitis risk (OR=1.62, 95%CI 1.19-2.22). In conclusion, this study found a significant association between IL-6 -572C/G polymorphism and chronic periodontitis risk.
Chronic periodontitis, Interleukin 6, Polymorphism
Chronic periodontitis is a multi-factorial infectious disease that occurs as a result of the host immune inflammatory response to pathogenic microorganisms, leading to the destruction of periodontal tissues, bone resorption and ultimately tooth loss . It is more likely that the cumulative effects of the disease occur over a lifetime. In addition to bacterial infection, individuals’ susceptibility to periodontitis is likely to be of major importance in determining the manifestation and progression of the disease .
Chronic periodontitis induces local and systemic elevation of proinflammatory cytokines, and these molecules contribute to soft and hard periodontal tissue destruction and loss of dental elements . Thus, inflammatory responses play an important role in the development of chronic periodontitis. Interleukin 6 (IL-6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine . It is a predominant cytokine associated with bone destruction in advanced periodontal disease . The level of IL-6 in the sera of periodontitis patients was seen to be higher than those of healthy controls . Previous studies investigated the association between the IL-6 -572C/G polymorphism and chronic periodontitis risk [7,8]. However, the results were inconclusive. Therefore, we performed this study to assess the association between IL-6 -572C/G polymorphism and chronic periodontitis risk.
A total of 490 subjects, including 231 patients with periodontitis and 259 controls, were suitable to participate in this study. Written informed consent was obtained from the patients who agreed to participate in the study. This study was approved by People's Hospital of Henan Province.
Genotyping of IL-6-572C/G polymorphism
The quality and the quantity of DNA were confirmed by agarose gel electrophoresis and spectrophotometry, respectively. IL-6 sequence amplification was done using polymerase chain reaction (PCR) with 3 thermal protocols of 94°C for 30 s, 56°C for 30 s and 72°C for 30 s. This cycle was repeated 30 times.
Results on continuous measurements are presented as mean ± SD and categorical measurements are presented in number (%). Student’s t test was used to find the significance of study parameters on a continuous scale between the two groups. Odds ratios (OR) and their corresponding 95% confidence intervals (CI) were used to assess the association of IL-6-572C/G polymorphism and chronic periodontitis risk. All statistical analyses were performed by SPSS software (20.0; SPSS, Inc., Chicago, IL, USA).
This was a case-control study with 58 females and 173 males in the study group (n=231) and 79 females and 180 males in the control group (n=259). There was no significant difference between the age and gender distribution between the study and control groups. Among periodontitis patients, 37.3% were smokers, while this was 21.2% among controls (P<0.05). All the periodontal parameters were significantly higher in the study group (Table 1).
|Characteristics||Chronic periodontitis (n=231)||Healthy controls (n=259)||p|
|Age (years)||45.0 ± 5.2||46.6 ± 4.1||>0.05|
|Smoking habit (%)||37.7%||21.2%||<0.05|
|Pocket depth (PD)||2.1 ± 0.6||1.8 ± 0.2||<0.05|
|Plaque index (PI)||2.2 ± 0.2||1.6 ± 0.3||<0.05|
|Gingival index (GI)||2.5 ± 0.3||1.8 ± 0.1||<0.05|
Table 1. Baseline characteristics of the patients and controls.
The genotype distributions and allele frequencies were showed in Table 2. Subjects with CG genotype showed an increased risk of chronic periodontitis (OR=1.52, 95%CI 1.06-2.21). In addition, individuals with GG genotype had a higher risk of chronic periodontitis (OR=4.53, 95%CI 1.43-14.21). Carriage of the G-allele was significantly associated with chronic periodontitis risk (OR=1.62, 95%CI 1.19-2.22).
|Genetic model||Case (n)||Control (n)||OR||95% CI||p|
Table 2. Genotype distributions and allele frequencies of this study.
We included 231 patients with chronic periodontitis and 259 healthy controls. We found that subjects with CG genotype showed an increased risk of chronic periodontitis. In addition, individuals with GG genotype had a higher risk of chronic periodontitis. Carriage of the G-allele was significantly associated with chronic periodontitis risk.
IL-6 is a pro-inflammatory cytokine that has different pleiotropic activities including induction of acute phase proteins and stimulation of T and B cells, synoviocytes and osteoclasts. These inflammatory reactions result in cartilage and bone damage as well as other systemic manifestations . Amr et al. found that No association was found between IL-6-572G/C gene polymorphism and rheumatoid arthritis . Ma et al. suggested that the -572 C>G polymorphism was proved to be significantly associated with hypertension . Shi et al. indicated that CC genotypes of the IL-6 gene polymorphisms at position -572 may confer a high risk of cervical cancer . Yin et al. suggested a significant association between the IL-6 gene -572 G allele and increased risk of type 2 diabetes mellitus . Qi et al. showed that IL-6-572 C/G polymorphism could decrease the risk of Alzheimer's disease .
In conclusion, this study found a significant association between IL-6-572C/G polymorphism and chronic periodontitis risk. Carriage of the G-allele was significantly associated with chronic periodontitis risk. Large well-designed cohort studies are needed to confirm our results.
- Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: Cellular and molecular mechanisms. J Periodontal Res 1993; 28: 478-486.
- Landi L, Amar S, Polins AS, Van Dyke TE. Host mechanisms in the pathogenesis of periodontal disease. Curr Opin Periodontol 1997; 4: 3-10.
- Ebersole JL, Cappelli D, Mott G, Kesavalu L, Holt SC, Singer RE. Systemic manifestations of periodontitis in the non-human primate. J Periodontal Res 1999; 34: 358-362.
- Su H, Lei CT, Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol 2017; 8: 405.
- Pradeep AR, Thorat MS. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial. J Periodontol 2010; 81: 214-222.
- George AK, Janam P. The short-term effects of non-surgical periodontal therapy on the circulating levels of interleukin-6 and C-reactive protein in patients with chronic periodontitis. J Indian Soc Periodontol 2013; 17: 36-41.
- Holla LI, Fassmann A, Stejskalová A, Znojil V, Vanĕk J, Vacha J. Analysis of the interleukin-6 gene promoter polymorphisms in Czech patients with chronic periodontitis. J Periodontol 2004; 75: 30-36.
- Jingjin L, Zemin G, Xin M, Donghong W, Jianhua G, Jie Y, Yonggong W. Correlation between an interleukin-6 -572C/G polymorphism and chronic periodontitis. Int J Periodontics Restorative Dent 2010; 30: 301-305.
- Kishimoto T. Interleukin-6: from basic science to medicine: 40 years inimmunology. Annu Rev Immunol 2005; 23: 1-21.
- Amr K, El-Awady R, Raslan H. Assessment of the -174G/C (rs1800795) and -572G/C (rs1800796) interleukin 6 gene polymorphisms in egyptian patients with rheumatoid arthritis. Maced J Med Sci 2016; 4: 574-577.
- Ma H, Sun G, Wang W, Zhou Y, Liu D, Tong Y, Lu Z. Association Between Interleukin-6 -572 C>G and -174 G>C Polymorphisms and Hypertension: A Meta-analysis of Case-control Studies. Medicine (Baltimore) 2016; 95: e2416.
- Shi WJ, Liu H, Wu D, Tang ZH, Shen YC, Guo L. Stratification analysis and case-control study of relationships between interleukin-6 gene polymorphisms and cervical cancer risk in a Chinese population. Asian Pac J Cancer Prev 2014; 15: 7357-7362.
- Yin YW, Sun QQ, Zhang BB, Hu AM, Liu HL, Wang Q, Zeng YH, Xu RJ, Zhang ZD, Zhang ZG. Association between the interleukin-6 gene -572 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 11,681 subjects. Ann Hum Genet 2013; 77: 106-114.
- Qi HP, Qu ZY, Duan SR, Wei SQ, Wen SR, Bi S. IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer's disease. PLoS One 2012; 7: e37858.